Renee RyanCEO at Cala Health
Renee Ryan has 25 years of building category-creating healthcare companies. Prior to joining Cala as CEO in August 2019, she led the health technology investments for Johnson & Johnson Innovation (JJDC) on the West Coast and Asia Pacific for 8 years. While at J&J, she made over 15 new investments, including the Series A for Cala Health. Previously, she was a healthcare investment banker at RW Baird, Jefferies and Goldman Sachs. Renee currently sits on the board of Neuropace and is a strategic advisor to MedTech Venture Partners.